Heart Fuel
A Familiar Workout, A Fresh Clue
We already know exercise is good for the heart. It builds a stronger pump, steadies rhythm, and helps people bounce back after trouble. What has been harder to pin down is the chemistry that turns a jog or a swim into those durable benefits.
A team led by Qingxun Hu at Shanghai University, working with collaborators at Tongji University, the Chinese Academy of Sciences’ Northwest Institute of Plateau Biology, Heidelberg University Hospital, and the University of Washington, has now mapped one of those chemical steps with unusual precision. Using glowing sensors that report on a molecule called NADPH inside living heart muscle cells, they found that exercise raises NADPH in the cell’s main compartment—the cytosol—while levels inside the mitochondria stay largely unchanged.
That compartment difference matters. NADPH is a workhorse reductant: it helps cells rebuild molecules and keep oxidative stress in check. Think of it as a rechargeable battery pack the cell carries for biosynthetic work and antioxidant defense. The team’s sensors, called iNap reporters, let them watch those batteries fill in real time after swimming or running routines in mice.
The Pathway That Tops Up the Batteries
Where does the extra cytosolic NADPH come from? The answer points to the pentose phosphate pathway, or PPP—a side route of sugar metabolism that peels off carbon from glucose and, in the process, generates NADPH. The rate-limiting enzyme at the entrance of that pathway is glucose-6-phosphate dehydrogenase, better known as G6PD.
Exercise dialed up G6PD in heart muscle. The researchers traced part of that rise to a transcription factor called SP1, which binds the G6PD gene’s control region and turns production higher. When they dialed G6PD down with short-hairpin RNA delivered by adeno-associated virus, or when they drained cytosolic NADPH with a specialized oxidase tool called TpNOX, the familiar “good” growth of heart cells that follows endurance training shrank. Heart weight relative to tibia length, cardiomyocyte cross-sectional area, and markers of healthy growth all eased off. Blocking the pathway did not wreck everyday pumping performance in the short term; it simply muted the adaptive hypertrophy that exercise normally produces.
How does NADPH tell a heart cell to grow? The work links the molecule to the HDAC3–C/EBPβ axis. HDAC3 is an enzyme that removes acetyl tags from proteins and can quiet certain gene programs; C/EBPβ is a transcription factor long known to restrain exercise-driven cardiac growth when its levels stay high. Higher NADPH dampens that brake. When the team restored HDAC3 activity or otherwise interfered with the NADPH signal, growth signals faded. In other words, the metabolic top-up is not decoration—it is part of the instruction set for physiological hypertrophy, the kind of healthy enlargement that comes with training rather than disease.
Protection When Flow Returns
Ischemia–reperfusion injury is the one-two punch of a blocked coronary artery followed by restored blood flow. The return of oxygen can trigger a burst of reactive oxygen species and cell death. Exercise is known to blunt that damage. Here, the same PPP–NADPH circuit proved essential for that protection.
Mice that swam before an experimental ischemia–reperfusion challenge fared better: smaller infarcts relative to the area at risk, healthier ratios of pro- and anti-apoptotic proteins such as Bax and Bcl-2, steadier glutathione balance, and lower markers of lipid peroxidation. Knocking down G6PD erased much of that shield. Four weeks later, exercised animals still showed better preserved heart function on echocardiography—unless the pathway had been blocked.
The message is hopeful and specific. Exercise does not merely toughen the heart in some vague way; it primes a defined metabolic checkpoint that both supports constructive growth and cushions the tissue when oxygen swings wildly.
A Compound From a High-Plateau Screen
If the pathway is a checkpoint, can anything other than a treadmill flip it? The group screened 310 compounds drawn from Tibetan traditional sources and zeroed in on a spermidine derivative they named lyciumspermidine-0527. In cells and in mice, the molecule directly activated G6PD, encouraged the enzyme to form active dimers, raised intracellular NADPH, and reduced injury after ischemia–reperfusion. Protection depended on G6PD: when the enzyme was knocked down, the compound lost its edge.
Safety checks in the reported experiments were encouraging. Across a range of doses in cultured neonatal rat cardiomyocytes and in multi-organ histology after short-term dosing in mice, the compound did not trigger obvious cytotoxicity or widespread tissue damage. Longer-term human relevance remains an open frontier—the work is preclinical, conducted in mice and cultured heart cells—but the finding offers a concrete chemical handle on a pathway exercise already uses.
What Comes Next
The study is careful about scope. Results come from rodent models and isolated cardiomyocytes; translation to people will need dose-finding, pharmacokinetics, and clinical endpoints no mouse can supply. The authors also note that cytosolic and mitochondrial NADPH pools are regulated somewhat independently, so therapies aimed at one compartment will need to respect that geography.
Still, the arc is bright. A familiar habit—moving the body—turns out to refill a cytosolic NADPH pool through the pentose phosphate pathway, release a molecular brake on healthy growth, and leave the heart better prepared for the shock of restored blood flow. A plant-inspired molecule can mimic part of that signal. For a field that has long sought “exercise mimetics,” that is a tangible place to start building.
"Altogether, these results show that PPP-derived NADPH is a critical metabolic checkpoint that regulates exercise-induced physiological cardiomyocyte growth and protects against IR-induced heart injury." — Qingxun Hu and colleagues